Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Chen Timothy Yung-Cheng, Director. Insider active across 1 company, notably BeiGene, Ltd.. Cumulatively, 2 disclosures have been logged. History available since 9 June 2021. The latest transaction was filed on 16 June 2021 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Timothy Yung-Cheng Chen is a Director at BeiGene, Ltd. He brings expertise in the biopharmaceutical and life sciences sectors. As a director, he is involved in the strategy and governance of the company. His knowledge of biotechnology is essential for BeiGene, Ltd.